Desert King
  • Home
  • About Us
  • Raw Materials
    • Quillaja Management
    • Yucca Management
    • Jojoba Management
  • Lines of Business
    • Pharmaceuticals
    • Animal Nutrition and Health
    • Food and Beverages
    • Personal Care and Cosmetics
    • Agriculture
    • Environment and Mining
  • Quality
  • News
  • Contact
  • English
  • Spanish
The Natural Choice The Natural Choice The Natural Choice The Natural Choice
  • Home
  • About Us
  • Raw Materials
    • Quillaja Management
    • Yucca Management
    • Jojoba Management
  • Lines of Business
    • Pharmaceuticals
    • Animal Nutrition and Health
    • Food and Beverages
    • Personal Care and Cosmetics
    • Agriculture
    • Environment and Mining
  • Quality
  • News
  • Contact
  • English
  • Spanish

Scientific Papers

0
By Desert King
In Scientific Papers
Posted 18 March, 2026

Ji, Y., et al. Exploring the Impact of Adjuvants on Vaccine Immunity Through Hematopoietic Cells. Vaccines (Basel), 2026 Feb 5, 14(2):155. PMID: 41746076

The paper explores how various adjuvants influence the immune response and hematopoietic pathways, particularly focusing on megakaryocytes and platelets, which are emerging as key players in [...]

READ MORE
0
By Desert King
In Scientific Papers
Posted 18 March, 2026

Sengupta, A. and Bhattacharyya, J. Overcoming Challenges in Dengue Vaccine Development: Advanced Delivery Approaches. Mol Pharm, 2026 Feb 15, PMID: 41693158

This paper addresses the critical global health challenge posed by dengue virus, emphasizing the complexities in developing a safe, effective, and long-lasting vaccine capable of protecting [...]

READ MORE
0
By Desert King
In Scientific Papers
Posted 18 March, 2026

Bülow, F.E., et al. A novel thin layer chromatography based method for the quantification of quillaic acid saponins. J Pharm Biomed Anal, 2026 Jun 15, 273:117409. PMID: 41687224

This paper presents a novel, cost-effective thin-layer chromatography (TLC) -based method for quantifying quillaic acid saponins, key bioactive compounds with significant medicinal and [...]

READ MORE
0
By Desert King
In Scientific Papers
Posted 18 March, 2026

Kallenberg, J., et al. Preparing for Tuberculosis Vaccine M72/AS01E Implementation: A Global Demand Forecast and Key Influential Factors. Infect Dis Ther, 2026 Feb 25, PMID: 41739348

This paper provides a comprehensive, data-driven forecast of global demand for the novel M72/AS01E tuberculosis vaccine, which has the potential to significantly reduce TB-related mortality [...]

READ MORE
 Enzymology and Structural Basis of Glycosyltransferases Involved in Saponin C28 Carboxylic Acid O‑d‑Fucosylation
0
By David Romero
In Scientific Papers
Posted 11 February, 2026

Enzymology and Structural Basis of Glycosyltransferases Involved in Saponin C28 Carboxylic Acid O‑d‑Fucosylation

Hudson, G.A., et al. Enzymology and Structural Basis of Glycosyltransferases Involved in Saponin C28 Carboxylic Acid OdFucosylation. JACS Au, 2025 Nov 24, 5(12):6011- 6024. PMID: 41450652   [...]

READ MORE
 QS-21: Structural insights, immunological mechanisms, and prospects for rational design of safer vaccine adjuvants
0
By David Romero
In Scientific Papers
Posted 11 February, 2026

QS-21: Structural insights, immunological mechanisms, and prospects for rational design of safer vaccine adjuvants

Hu, Y., et al. QS-21: Structural insights, immunological mechanisms, and prospects for rational design of safer vaccine adjuvants. Eur J Med Chem, 2026 Jan 5, 301:118223. PMID: 41046625   [...]

READ MORE
 TB vaccine development: monitoring international patent filings to anticipate access challenges
0
By David Romero
In Scientific Papers
Posted 11 February, 2026

TB vaccine development: monitoring international patent filings to anticipate access challenges

Pignataro, M.F., et al. TB vaccine development: monitoring international patent filings to anticipate access challenges. Front Public Health, 2026 Jan 16, 13:1726153. PMID: 41626371   This [...]

READ MORE
 Immunogenicity of a Recombinant Zoster Vaccine (gE/BFA01) in Mice
0
By David Romero
In Scientific Papers
Posted 10 February, 2026

Immunogenicity of a Recombinant Zoster Vaccine (gE/BFA01) in Mice

Quan, Y., et al. Immunogenicity of a Recombinant Zoster Vaccine (gE/BFA01) in Mice. Viruses, 2025 Dec 30, 18(1):53. PMID: 41600818   This study addresses the significant public health [...]

READ MORE
 Ferguson, M., et al. Immune persistence and safety of the AS01E-adjuvanted respiratory syncytial virus prefusion F protein-based vaccine in adults 50-59 years of age, including at-increased-risk adults: A randomized controlled trial. Hum Vaccin Immunother, 2025 Dec, 21(1):2579335. PMID: 41194599
0
By Desert King
In Scientific Papers
Posted 19 January, 2026

Ferguson, M., et al. Immune persistence and safety of the AS01E-adjuvanted respiratory syncytial virus prefusion F protein-based vaccine in adults 50-59 years of age, including at-increased-risk adults: A randomized controlled trial. Hum Vaccin Immunother, 2025 Dec, 21(1):2579335. PMID: 41194599

Respiratory syncytial virus (RSV) is a leading cause of respiratory illness across all age groups, particularly affecting infants, older adults, and individuals with chronic health conditions, [...]

READ MORE
 Rayens, E., et al. Adjuvanted Recombinant Zoster Vaccine is Effective Against Herpes Zoster Ophthalmicus, and is Associated With Lower Risk of Acute Myocardial Infarction and Stroke in Adults Aged ≥50 Years. Clin Infect Dis, 2025 Dec 24, 81(5):e441-e445. PMID: 40795767
0
By Desert King
In Scientific Papers
Posted 19 January, 2026

Rayens, E., et al. Adjuvanted Recombinant Zoster Vaccine is Effective Against Herpes Zoster Ophthalmicus, and is Associated With Lower Risk of Acute Myocardial Infarction and Stroke in Adults Aged ≥50 Years. Clin Infect Dis, 2025 Dec 24, 81(5):e441-e445. PMID: 40795767

Herpes zoster (shingles) and its complication, herpes zoster ophthalmicus (HZO), are associated with an increased risk of cardiovascular events such as heart attacks and strokes, especially in [...]

READ MORE

DESERT KING INTERNATIONAL
745 Main Street-
Chula Vista, CA, USA, 91911
+1 619 429 5222
info@desertking.com

DESERT KING CHILE
Avenida Industrial 1970
Quilpué, Chile, 2420505
+56 32 292 5020
info@desertking.cl

DESERT KING MEXICO
Camino Vecinal 11500-A
Tijuana B.C., México, 22664
+52 664 636 11 24
info@desertkingmexico.com

Privacy Policy
© 2025 Desert King. All Right Reserved

Start typing and press Enter to search